Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1603 |
|---|---|
| Identifier | NCT03398135 |
| Trial Title | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: risankizumab|DRUG: placebo for risankizumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Coronado |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-08-28 |
|---|---|
| Primary Completion Date | 2025-09-28 |
| Completion Date | 2025-09-28 |